AAVINUE
PrivateLast Round
Accelerator
Dec 13, 2023
Company Overview
AAVINUE is a biotechnology company developing a non-viral gene delivery technology based on a proprietary mini-nucleosome platform to treat genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AAVINUE Comparables
Compare AAVINUE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mediphage Bioceuticals | 87% | |
| Code Biotherapeutics | 86% | |
| Anjarium Biosciences | 79% |
AAVINUE Funding Rounds
Historical fundraising activity
AAVINUE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Biomedical Initiatives | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 13, 2023
Received funding from Massachusetts Biomedical Initiatives.
AAVINUE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AAVINUE's valuation, stock price, and market status.
Is AAVINUE a public or private company?
AAVINUE is a private company.
What is the current stock price of AAVINUE?
AAVINUE is a private company, so its shares have no public market price. Caplight tracks AAVINUE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AAVINUE worth (valuation)?
Valuation information for AAVINUE is not publicly available.
Can I buy AAVINUE stock?
AAVINUE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AAVINUE's last funding round?
AAVINUE's most recent funding round was Accelerator on December 13, 2023.
Who are the main investors in AAVINUE?
Key investors in AAVINUE include Massachusetts Biomedical Initiatives.
Will AAVINUE IPO soon?
No public IPO plans have been announced for AAVINUE.
How can I track AAVINUE secondary market activity?
Caplight tracks bids, offers, and trades in AAVINUE's shares on secondary markets.